First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT05494918
- Locations
- 🇦🇺
Breast Cancer Research Centre, Perth, Western Australia, Australia
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT03529526
- Locations
- 🇦🇺
ICON Cancer Care, Southport, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath